Certificati di investimento - Cap. 3 (11 lettori)
- Creatore Discussione Siloso
- Data di Inizio
- Stato
Fabrib
Forumer storico
The Lancet has published the results from a study in China testing Gilead Sciences' remdesivir in severely ill hospitalized COVID-19 patients with acute respiratory distress syndrome.
237 patients were enrolled across 10 hospitals in Hubei province, 158 received remdesivir and 79 placebo. Patients were allowed concomitant treatment with lopinavir–ritonavir, interferons, and corticosteroids.
The primary endpoint was time to clinical improvement up to day 28 defined as the time from randomization to the point of decline of two points on a six-point scale of clinical status (1=discharged to 6=death).
Patients receiving remdesivir within 10 days of symptom onset experienced numerically faster times to clinical improvement but the results were not statistically significant.
On the safety front, the incidence of adverse events was 66% in the remdesivir arm compared to 64% in the control arm.
The investigators concluded that additional studies were needed to prove clinical benefit.
The study was terminated early due to low enrollment. SA
237 patients were enrolled across 10 hospitals in Hubei province, 158 received remdesivir and 79 placebo. Patients were allowed concomitant treatment with lopinavir–ritonavir, interferons, and corticosteroids.
The primary endpoint was time to clinical improvement up to day 28 defined as the time from randomization to the point of decline of two points on a six-point scale of clinical status (1=discharged to 6=death).
Patients receiving remdesivir within 10 days of symptom onset experienced numerically faster times to clinical improvement but the results were not statistically significant.
On the safety front, the incidence of adverse events was 66% in the remdesivir arm compared to 64% in the control arm.
The investigators concluded that additional studies were needed to prove clinical benefit.
The study was terminated early due to low enrollment. SA
BRUNO66
Forumer storico
Io invece non ho resistito al richiamo del gain e ho venduto (411) forse sprecandolo ; ma per me vale sempre il proverbio "vendi guadagna e pentiti" (soprattutto in questo periodo magra).
CarloConti
Forumer storico
se oggi (ma non rileva oggi purtroppo) recuperano alla grande il trigger cedola anche gap e guess nel XS2027818454 davvero è una gran giornata.
oldmouseit
Forumer storico
beh non va bene neanche pagare 400 una cosa che ne vale 40... (Antonveneta/Mps/Santander docet)
Fabrib
Forumer storico
The flood of Americans seeking unemployment benefits after losing their jobs in the coronavirus pandemic is slowing, but another several million Americans probably filed jobless claims to bump to total to almost 30 million in the latest week.
Initial jobless claims likely rose about 3.5 million in the week running from April 19 to April 25, according to economists polled by MarketWatch. That would be half as many as during the pandemic peak, but still shockingly high. Just a few months ago, claims were running in the low 200,000s and stood at a 50-year low. The Labor Department is due to publish the latest data on Thursday. MW
Initial jobless claims likely rose about 3.5 million in the week running from April 19 to April 25, according to economists polled by MarketWatch. That would be half as many as during the pandemic peak, but still shockingly high. Just a few months ago, claims were running in the low 200,000s and stood at a 50-year low. The Labor Department is due to publish the latest data on Thursday. MW
NoWay
It's time to play the game
Pensa che lo fanno pure certe Regioni senza neppure ricevere il dovuto...
oldmouseit
Forumer storico
sotto casa mia è pieno di gente che corre, posso rapinare una banca?
NoWay
It's time to play the game
NoWay
It's time to play the game
- Stato